Table 3B.
| B. At delivery | |||||||
|---|---|---|---|---|---|---|---|
|
| |||||||
| Group | Mean (SE) log10 HIV load at baselinea |
Mean (SE) log10 HIV load at delivery |
Crude mean difference (95% CI) |
Adjusted mean difference (95% CI)b |
p | ||
| Placebo | Albendazole | Placebo | Albendazole | ||||
| All women | 4.16 (0.09) | 4.05 (0.08) | 4.10 (0.09) | 3.83 (0.08) | −0.27 (−0.51, −0.03) | −0.11 (−0.28, 0.07) | 0.23 |
| Hookworm infected | 4.27 (0.13) | 4.12 (0.14) | 4.10 (0.14) | 3.87 (0.14) | −0.24 (−0.63, 0.16) | −0.00 (−0.25, 0.25) | 0.43c |
| Hookworm uninfected | 4.09 (0.12) | 4.03 (0.10) | 4.10 (0.12) | 3.81 (0.10) | −0.29 (−0.60, 0.03) | −0.17 (−0.42, 0.07) | |
|
| |||||||
| Placebo | Praziquantel | Placebo | Praziquantel | ||||
|
| |||||||
| All women | 4.04 (0.08) | 4.05 (0.09) | 3.94 (0.08) | 3.99 (0.09) | 0.05 (−0.20, 0.29) | 0.04 (−0.13, 0.21) | 0.64 |
| S. mansoni infected | 3.86 (0.17) | 4.12 (0.21) | 3.69 (0.20) | 4.04 (0.24) | 0.35 (−0.27, 0.97) | 0.10 (−0.22, 0.42) | 0.50c |
| S. mansoni uninfected | 4.09 (0.09) | 4.03 (0.10) | 4.00 (0.09) | 3.98 (0.10) | 0.02 (−0.25, 0.29) | 0.01 (−0.19, 0.21) | |
a
For those with viral load measured at delivery
b
For effect of albendazole treatment, results were adjusted for baseline viral load and baseline malaria parasitaemia; for effect of praziquantel treatment, results were adjusted for baseline viral load
c
Interaction p-value
SE=standard error; CI=confidence interval